Effect and efficacy - On the function of models in controlled phase III trials and the need for prospective Pharmacoepidemiological studies

Pharmacopsychiatry

Volumn 29, Issue 4, 1996, Pages 135-141

  Winterer, G ^a   Herrmann, W M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; DATA ANALYSIS; DRUG APPROVAL; DRUG EFFICACY; DRUG RESPONSE; HUMAN; METHODOLOGY; MODEL; PHARMACOEPIDEMIOLOGY; PHASE 3 CLINICAL TRIAL; PHASE 4 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL;

EID: 0030036808     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979559     Document Type: Article

References (48)

1. Albert H.: Theorie und Realität. Mohr, Tübingen 1972
2. Angst, J., P. Bech, J. Bruinvels, R. R. Engel, U. Ferner, J. D. Guelfi, O. Lingjaerde, B. Müller-Oerlinghausen, M. Paes de Sousa, E. Paykel, R. Rimon, M. Rzewuska, B. Saletu, R. Spiegel, H. H. Stassen, K. D. Stoll, F. A. Wiesel, B. Woggon, P. Zvolski: Report on the fifth consensus conference: methodology of long-term clinicial trials in psychiatry. Pharmacopsychiatry 27 (1994) 101-107
3. Ansseau, M.: The Atlantic gap: clinical trials in Europe and the United States. Biol. Psychiatr. 31 (1992) 109-111
4. Bortz, J.: Statistik für Sozialwissenschaftler. Springer, Berlin, Heidelberg, New York 1989
5. Cicourel, A. V.: Methode und Messung in der Soziologie. Suhrkamp, Frankfurt 1970
6. Cook, D. J., D. L. Sackett, W. O. Spitzer: Methodological guidelines for systematic reviews of randomized control trials in health care from the Potsdam consultation on meta-analysis. J. Clin. Epidemiol. 48 (1) (1995) 167-171
7. De Groat, A. D.: Methodology. The Hague, Mouton 1969
8. Farmer, R. D. T., R. M. Pinder: Why do fatal overdose rates vary between antidepressants? Acta Psychiatr. Scand. 80 (1989) (Suppl. 354) 25-35
9. Fish, B. J., T. A. Pedley: The role of quantitative topographic mapping or neurometrics in the diagnosis of psychiatric and neurological disorders. Electroenceph. Clin. Neurophysiol. 73 (1989) 5-9
10. Fish, B. J., T. A. Pedley: The role of quantitative topographic mapping or neurometrics in the diagnosis of psychiatric and neurological disorders. Electroenceph. Clin. Neurophysiol. 73 (1989) 5-9
11. Foucault, M.: Histoire de la folie. Librairie Plan, Paris 1961
12. Geiselmann, B., M. Linden: Prescription and intake patterns in long-term and ultra-long-term benzodiazepine treatment in primary care practice. Pharmacopsychiatry 24 (1991) 55-61
13. Hamm, H.: Arzneimittelprüfung in der Allgemeinpraxis. Praktischer Arzt 27 (1983) 2135-2139
14. Herrmann, W. M., J. Schuster, C. Stille: Gedanken zur Phase-III-Prüfung zum Nachweis der therapeutischen Wirksamkeit von Gerontopharmaka. In: Oswald, W. D., U. M. Fleischmann (eds.), Experimentelle Gerontopsychologie. Weinheim, Beltz (1981) 23-35
15. Herrmann, W. M., E. Schärer: The long-term tolerability of bencyclane fludilat in patients with peripheral occlusive disease: a 48-week prospective double-blind controlled study versus placebo, Pharmacotherapeutica/Current Medical Research and Opinion Vol. 12 (1991) 356-365
16. Honkela, T., V. Pulkki, T. Kohonen: Contextual relations of words in Grimm tales, analyzed by selforganizing map. International Conference on Neural Networks (ICANN'95), 1995
17. Idänpään-Heikkila, J., E. Alhava, M. Olkinuora, L. P. Palva: Agranulocytosis during treatment with clozapine. Eur. J. Clin. Pharmacol. 11 (1977) 193-198
18. Janfee, W.: Response variability to psychotropic drugs: Overview of the main approaches to differential pharmacopsychology. In: Janke, W. (ed.): Response variability to psychotropic drugs. Pergamon, Oxford 1983
19. Johnson, D. A. W.: Depression: Treatment compliance in general practice. Acta Pspychiat. Scand. Suppl. 290, 63 (1981) 447-453
20. Jungi, W., J. Fischer, H. Seen: Gehäufte durch Clozapin (Leponex) induzierte Agranulozytosen in der Ostschweiz? Schweiz. Med. Wochenschr. 107 (1977) 1861-1864
21. Kaski, S., T. Kohonen: Structures of welfare and poverty in the world discovered by the self-organizing map. Report A24, Helsinki University of Technology, Laboratory of Computer and Information Science, 1995
22. Kern, U.: Problems of generalization of findings, regulatory attitudes. Eur. Psychiatr. 9 (1994) 143-144
23. Kline, N. D.: A controlled comparison of trimipramine and amitriptyline. J. Clin. Psychiatry 43 (1982) 100-104
24. Kohonen, T.: Self-organizing maps. Springer Series in Information Sciences, Vol. 30. Springer, Berlin Heidelberg, New York 1995
25. Kuhn, Th. S.: The structure of scientific revolutions. Chicago 1962
26. Linden, M.: Phase-IV Forschung. Antidepressiva in der Nervenarztpraxis. Springer, Berlin, Heidelberg, New York 1987
27. Linden, M., W. Gaebel, H. Gutzmann, L. Lachmund., W. Otto, F. M. Reischies, G. Schüssler: Behandlung von schizophrenen Patienten mit Neuroleptika durch niedergelassene Nervenärzte. In: Helmchen, H., H. Hippius, R. Tölle (eds.). Therapie mit Neuroleptika. Thieme, Stuttgart (1988), 110-117
28. Linden, M.: Epidemiological methods in the evaluation of drugs: Field studies in the postmarketing phase. Pharmacopsychiatry 25 (1992) 67-68
29. Linden, M.: Postmarketing surveillance of psychotherapeutic medications: A challenge for the 1990's. Psychopharmacol. Bull. 29 (1993) 51-56
30. Martin-del-Brio, B., C. Serrano-Cinca: Self-organizing neural networks for the analysis and representation of data: Some financial cases. Neural Computing & Application 1 (1993) 193-206
31. Maturana, H. R., F. J. Varela: Autopoiesis and cognition. The realization of the living. In: Cohen, R. S., M. W. Wartowsky (eds.): The philosophy of science, Vol. 42. D. Reidel Publishing, Dordrecht, Boston, London 1980
32. McGuire, M., M. J. Raleigh, C. Brammer: Sociopharmacology. Ann. Rev. Pharmacol. Toxicol. 22 (1982) 643-661
33. Pietzcker, A., W. Gaebel, W. Köpcke, M. Linden, P. Müller, F. Müller-Spahn, G. Schüssler, J. Tegeler: A german multicenter study on the neuroleptic long-term therapy of schizophrenic patients. Pharmacopsychiatry 19 (1986) 161-166
34. Popper, K: The logic of scientific discovery. Hutchinson, London 1959
35. Rein, W., P. L. Morselli: Patient sampling in anxiety studies: factors influencing response rate. Eur. Psychiatr. 9 (1994) 137-139
36. Rosenblueth, A., N. Wiener: The role of models in science. Philos. Sci. 12 (1945) 316-321
37. Rüther, E., O. Benkert, F. Eckmann: Drug Monitoring in psychiatrischen Kliniken. Arzneimittelforschung 30 (1980) 1181-1183
38. Schmidt, L. G., H. Czerlinsky, M. Stöckel: Longitudinal assessment of psychotropic drug use in acutely-ill psychiatric inpatients. Int. J. Clin. Pharmacol. Ther. Toxicol. 25 (1987) 244-250
39. Spitzer, W. O.: Meta-meta-analysis: unanswered questions about aggregating data. J. Clin. Epidemiol. 44 (1991) 103-107
40. Spitzer, W. O.: The challenge of meta-analysis. J. Clin. Epidemiol. 48 (1995) 1-4
41. Stachowiak, H.: Allgemeine Modelltheorie. Springer, Wien 1973
42. Suissa, S., P. Ernst, J.-F. Boivin, R. I. Horwitz, B. Habbick, D. Cockroft, L. Blais, M. McNutt, A. S. Buist, W. O. Spitzer: A cohort analysis of excess mortality in asthma and the use of β-agonists. Am. J. Respir. Crit. Care Med. 149 (1994) 604-610
43. Stassen, H. H., J. Angst, A. Delini-Stula: Severity at baseline and onset of improvement in depression. Meta-analysis of imipramine and moclebemide vs. placebo. Eur. Psychiatr. 9 (1994) 1291-136
44. Volz, H.-P., H.-J. Möller: Antidepressant drug therapy in the elderly - a critical review of the controlled clinical trials conducted since 1980. Pharmacopsychiatry 27.(1994) 93-100
45. WHO (World Health Organization): Dose effects of antidepressant medication in different populations. A World Health Organization collaborative study. J. Affect. Dis. Suppl. 2 (1986) S1-S76
46. Winterer, G., N. Postnikov, M. Ziller, E. Niestroj, K. Frick, A. Heinz, S. Marquardt, M. Lewinsky, W. M. Herrmann: Signalkomplexität versus Spektralparameter in EEG-Zeitreihen von psychiatrischen Patienten: Eine retrospektive Klassifikationsstudie. Z. EEG-EMG 26 (1995) 61-71
47. Wittgenstein, L.: Über Gewißheit. Suhrkamp Wissenschaft, Frankfurt 1984
48. Wolffgramm, J.: Sozipharmakologie psycho-aktiver Substanzen: Einflüsse auf Wirkung und Einnahmeverhalten. In: Heinrich, K., M. Linden, B. Müller-Oerlinghausen (eds.). Werden zu viele Psychopharmaka verbraucht? Thieme, Stuttgart (1989) 110-117